Drug Guide
Tromethamine
Classification
Therapeutic: alkalizing agent
Pharmacological: buffer
FDA Approved Indications
- Used as a pH buffer in metabolic acidosis and in certain blood transfusion procedures
Mechanism of Action
Tromethamine (Tham) acts as a proton acceptor, buffering excess hydrogen ions in the blood to help correct acid-base disturbances, primarily metabolic acidosis.
Dosage and Administration
Adult: Dosage varies based on clinical condition; typically administered intravenously as directed by a healthcare professional.
Pediatric: Use is based on individual clinical assessment, dosing calculations should consider age and weight.
Geriatric: Adjust doses carefully considering renal function and overall health status.
Renal Impairment: Use cautiously; dosage adjustments may be necessary due to altered clearance.
Hepatic Impairment: No specific adjustments; use with caution.
Pharmacokinetics
Absorption: Not applicable (administered IV)
Distribution: Distributed in extracellular fluid; crosses the blood-brain barrier
Metabolism: Limited metabolism; primarily acts as a buffer
Excretion: Renally excreted as unchanged drug and metabolites
Half Life: Various, generally a few hours depending on renal function.
Contraindications
- Metabolic or respiratory alkalosis; hypersensitivity to tromethamine.
Precautions
- Use with caution in patients with renal impairment, heart failure, or edema due to risk of fluid overload.
Adverse Reactions - Common
- Electrolyte imbalance (e.g., hypernatremia, hyperkalemia) (Uncommon)
- Edema or fluid overload (Uncommon)
Adverse Reactions - Serious
- Alkalosis (Rare)
- Cardiac arrhythmias, especially in susceptible individuals (Rare)
Drug-Drug Interactions
- Caution with other alkalizing agents or medications affecting electrolyte balance.
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor serum electrolytes, blood pH, and fluid status.
Diagnoses:
- Electrolyte imbalance, Risk for fluid overload.
Implementation: Administer IV as prescribed, monitor vital signs, and blood chemistry regularly.
Evaluation: Assess effectiveness by stabilization of acid-base status and correction of electrolyte imbalances.
Patient/Family Teaching
- Report signs of fluid overload (e.g., swelling, shortness of breath).
- Follow medical instructions carefully regarding dosing and administration.
Special Considerations
Black Box Warnings:
- Use cautiously in patients at risk for alkalosis or electrolyte imbalance.
Genetic Factors: N/A
Lab Test Interference: Can alter serum electrolyte measurements and blood pH readings.
Overdose Management
Signs/Symptoms: Metabolic alkalosis, hypokalemia, hypernatremia, fluid overload.
Treatment: Discontinue drug, provide supportive care, correct electrolyte disturbances, administer diuretics if necessary.
Storage and Handling
Storage: Store at room temperature, away from moisture and light.
Stability: Stable under recommended storage conditions.